Skip to main content
Log in

Cognition-enhancing intervention for first-episode psychosis improves outcomes at acceptable cost in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Breitborde NJK, et al. Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation. Cost Effectiveness and Resource Allocation : 1 Jul 2021. Available from: URL: https://doi.org/10.1186/s12962-021-00292-6

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cognition-enhancing intervention for first-episode psychosis improves outcomes at acceptable cost in the US. PharmacoEcon Outcomes News 882, 3 (2021). https://doi.org/10.1007/s40274-021-7837-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7837-2

Navigation